BehaveNet® Clinical Capsule™:

DSM-IV: Sedative, Hypnotic, or Anxiolytic Withdrawal


The brain adapts to use of a sedative, hypnotic, or anxiolytic in such a way that symptoms may result when the substance is reduced or discontinued, leading to diagnosis of this Substance-Related Disorder.

Diagnostic criteria for 292.0 Sedative, Hypnotic, or Anxiolytic Withdrawal
(cautionary statement)  

A. Cessation of (or reduction in) sedative, hypnotic, or anxiolytic use that has been heavy and prolonged. 

B. Two (or more) of the following, developing within several hours to a few days after Criterion A: 

(1) autonomic hyperactivity (e.g., sweating or pulse rate greater than 100) 
(2) increased hand tremor 
(3) Insomnia 
(4) nausea or vomiting 
(5) transient visual, tactile, or auditory hallucinations or illusions
(6) psychomotor agitation 
(7) anxiety
(8) grand mal seizures 

C. The symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. 

D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.
Specify if: 
With Perceptual Disturbances

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, fourth Edition. Copyright 1994 American Psychiatric Association

 


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2008 BehaveNet®